5^th Global Summit on Cancer October 28-29, 2021 Tokyo, Japan

With people from around the world focused on getting some answers concerning Oncology and Cancer; this is your most obvious opportunity to accomplish the greatest cluster of individuals from the Cancer people group, Oncology Society, European Oncology Conferences, Hematology conferences, Pharmacology conferences. Coordinate presentations, disperse information, meet with present and potential specialists, make a sprinkle with new pharmaceutical progressions, and get name affirmation at this three day event. Broadly acclaimed speakers, the most recent systems, changes, and the most a la mode invigorates in Oncology are indications of this meeting.

·         Oncologists

·         Radiologists

·         Pathologists

·         Students

·         Oncology Associations & Societies

·         Business Entrepreneurs

·         Hematologists

·         Academicians

·         Research Scholars

·         Software Developing Companies

·         Medical Devices Companies

·         Biomedical Companies

·         Biotechnology Companies

·         Data Management Companies

• Organ-Defined Cancers
• Types of Oncology
• Cancer Immunotherapy
• Cancer Pharmacology
• Prognosis in Cancer
• Cancer Biomarkers
• Cancer Metabolomics
• Oncology Nursing and Care
• Radiation Oncology
• Cancer & Stem Cell Therapy
• Cancer Treatments and Therapy
• Vaccines involvement in Cancer
• Gynecologic Oncology
• Trends in Cancer Research and Chemotherapy

Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors.

2021 Global Cancer will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Cancer in adults & cancer in children.

North America is the leading regional marketplace for cancer diagnostics with a part of approximately 40.7% of the general cancer diagnostics market in terms of income in 2015, shadowed by Europe which accounted for around 29.1% share in the market.

Worldwide

• Emory University
• Karolinska University
• University of Cambridge
• University of Oxford Stanford University
• UNC School of Medicine
• Harvard University
• Mayo Medical School
• Yale University
• University of Minnesota
• John Hopkins University
• Pittsburgh School of Medicine
• University of Wisconsin
• Kings College London
• Feinberg School of Medicine

In Asia Pacific

• The University of Tokyo
• University of Delhi
• KAIST - Korea Advanced Institute of Science and Technology
• National University of Singapore (NUS)
• Kyoto University
• University of Hong Kong (HKU)
• Peking University
• Seoul National University (SNU)
• National Taiwan University (NTU)
• Osaka University
• Tsinghua University0
• The Chinese University of Hong Kong (CUHK)
• Fudan University
• The Hong Kong University of Science and Technology (HKUST)
• Shanghai Jiao Tong University
• Mahidol University
• Korea University
• Beijing University of Chinese Medicine
• Taipei Medical University
• Beijing Institute of Technology
• Yonsei University
• Nanyang Technological University (NTU)
• Chulalongkorn University
• Tohoku University
• Tokyo Medical and Dental University
• Kyushu University
• Nagoya University
• Hokkaido University
• Sungkyunkwan University
• University of Science and Technology of China
• Pohang University of Science and Technology (POSTECH)
• Universiti Malaya (UM)
• Zhejiang University
• Keio University
• Indian Institute of Science
• Tokyo Institute of Technology
• Universiti Kebangsaan Malaysia (UKM)
• Universiti Sains Malaysia (USM)
• Nanjing University
• Kyung Hee University
• National Yang Ming University
• University of Indonesia
• University of the Philippines
• University of Tsukuba
• Bandung Institute of Technology (ITB)
• Hanyang University
• Indian Institute of Technology Bombay (IITB)
• National Cheng Kung University
• Universiti Putra Malaysia (UPM)

Major Cancer Associations:

Worldwide

• American Association for Cancer Research
• Virginia Cancer Institute
• American Brain Tumor Association
• American Society of Pediatric Hematology/Oncology
• Association of Cancer Physicians
• American Childhood Cancer Organization
• American Society of Clinical Oncology
• Australasian Lung Cancer Trials Group
• International Cancer Research Partnership (ICRP)
• American Association for Cancer Research (AACR)
• American Society of Clinical Oncology (ASCO)
• International Agency for Research on Cancer (IARC)
• Cancer Society of New Zealand
• Irish Cancer Society

• Australian Cervical Cancer Foundation
• Medical Centre Cologne
• Cancer Research UK
• Australian Prostate Cancer Research
• Peter McCollum Cancer Centre
• The European Cancer Organization (ECCO)
• German Cancer Research Centre

In Asia Pacific

• Medical Excellence JAPAN
• Japan Community Health care Organization Chukyo Hospital
• Aichi Cancer Center Hospital
• Japanese Red Cross Nagoya Daiichi Hospital
• Kyoto University Hospital
• Dokkyo Medical University Hospital
• Japan Hospital Association
• Aizawa Hospital
• Medical Excellence JAPAN
• Japan Community Health care Organization Chukyo Hospital
• Aichi Cancer Center Hospital
• Japanese Red Cross Nagoya Daiichi Hospital
• Kyoto University Hospital
• Dokkyo Medical University Hospital
• Japan Hospital Association
• Aizawa Hospital
• University Hospital Kumamoto University
• International Medical Center of Japan
• The Asia-Pacific Urogynecology Association
• The Asia-Pacific Cancer Society Training
• Asian Cancer Foundation India
• The Max Foundation
• Childhood Cancer International Netherlands
• The Asia Pacific Prostate Society

The global cancer diagnostics market is expected to grow at a CAGR of 11.8% during the forecast period 2017-2023. There are several methods of diagnosing cancer today such as biopsy based, endoscopy based, imaging procedure, tumor cancer diagnostics and many more. Population affected with cancer is showing a tremendous growth during last few years, which create the requirement of advanced technology for diagnosis cancer on early stage. According to the American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will be diagnosed and around 26,730 deaths occur owing to prostate cancer in the United States. Thus, many companies are involved in collaboration in order to provide better technology for diagnosis the cancer. In this regards, in January, 2015, Roche and Qualcomm Incorporated entered into a strategic collaboration to improve remote monitoring and management of patients with chronic disease.

Major Cancer- Pharma Companies:

The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year.

Annual global growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.

About $51.2 billion in 2017 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.